These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 8396624

  • 1. In vitro activity of cefodizime (HR-221) in combination with beta-lactamase inhibitors.
    Segatore B, Perilli M, Franceschini N, Setacci D, Oratore A, Amicosante G.
    J Chemother; 1993 Jun; 5(3):147-50. PubMed ID: 8396624
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria.
    Kitzis MD, Ferré B, Coutrot A, Acar JF, Gutmann L.
    Eur J Clin Microbiol Infect Dis; 1989 Sep; 8(9):783-8. PubMed ID: 2556277
    [Abstract] [Full Text] [Related]

  • 3. In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.
    Muratani T, Yokota E, Nakane T, Inoue E, Mitsuhashi S.
    J Antimicrob Chemother; 1993 Sep; 32(3):421-9. PubMed ID: 8262864
    [Abstract] [Full Text] [Related]

  • 4. Activity of 13 beta-lactam agents combined with BRL 42715 against beta-lactamase producing gram-negative bacteria compared to combinations with clavulanic acid, tazobactam and sulbactam.
    Piddock LJ, Jin YF, Turner HL.
    J Antimicrob Chemother; 1993 Jan; 31(1):89-103. PubMed ID: 8383105
    [Abstract] [Full Text] [Related]

  • 5. Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes.
    Appelbaum PC, Jacobs MR, Spangler SK, Yamabe S.
    Antimicrob Agents Chemother; 1986 Nov; 30(5):789-91. PubMed ID: 3026241
    [Abstract] [Full Text] [Related]

  • 6. Evolution of beta-lactamase inhibitors.
    Rolinson GN.
    Rev Infect Dis; 1991 Nov; 13 Suppl 9():S727-32. PubMed ID: 1656513
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors.
    Tajada P, Gomez-Graces JL, Alós JI, Balas D, Cogollos R.
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1924-5. PubMed ID: 8843305
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of beta-lactamases by tazobactam and in-vitro antibacterial activity of tazobactam combined with piperacillin.
    Higashitani F, Hyodo A, Ishida N, Inoue M, Mitsuhashi S.
    J Antimicrob Chemother; 1990 Apr; 25(4):567-74. PubMed ID: 2161820
    [Abstract] [Full Text] [Related]

  • 9. Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents.
    Lachance N, Gaudreau C, Lamothe F, Turgeon F.
    Antimicrob Agents Chemother; 1993 May; 37(5):1174-6. PubMed ID: 8390812
    [Abstract] [Full Text] [Related]

  • 10. Effect of beta-lactamase inhibitors on beta-lactamases from anaerobic bacteria.
    Hedberg M, Lindqvist L, Tunér K, Nord CE.
    Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1100-4. PubMed ID: 1338315
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of beta-lactamase inhibitors against clinical isolates of Acinetobacter species.
    Suh B, Shapiro T, Jones R, Satishchandran V, Truant AL.
    Diagn Microbiol Infect Dis; 1995 Feb; 21(2):111-4. PubMed ID: 7628190
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
    Qadri SM, Ueno Y, Cunha BA.
    Chemotherapy; 1996 Feb; 42(5):334-42. PubMed ID: 8874972
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed Class I beta-lactamases.
    Akova M, Yang Y, Livermore DM.
    J Antimicrob Chemother; 1990 Feb; 25(2):199-208. PubMed ID: 2158496
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antibacterial activity of clavulanate and tazobactam on Peptostreptococcus spp.
    Reig M, Baquero F.
    J Antimicrob Chemother; 1994 Feb; 33(2):358-9. PubMed ID: 8182024
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.